ARKEMA (AKE.PA) Stock Fundamental Analysis

EPA:AKE • FR0010313833

62.5 EUR
-1.3 (-2.04%)
Last: Feb 16, 2026, 07:00 PM
Fundamental Rating

4

We assign a fundamental rating of 4 out of 10 to AKE. AKE was compared to 66 industry peers in the Chemicals industry. AKE has an average financial health and profitability rating. AKE has a valuation in line with the averages, but it does not seem to be growing.


Dividend Valuation Growth Profitability Health

4

1. Profitability

1.1 Basic Checks

  • In the past year AKE was profitable.
  • In the past year AKE had a positive cash flow from operations.
  • Each year in the past 5 years AKE has been profitable.
  • Each year in the past 5 years AKE had a positive operating cash flow.
AKE.PA Yearly Net Income VS EBIT VS OCF VS FCFAKE.PA Yearly Net Income VS EBIT VS OCF VS FCFYearly Net Income VS EBIT VS OCF VS FCF 2016 2017 2018 2019 2020 2021 2022 2023 2024 500M 1B

1.2 Ratios

  • AKE has a Return On Assets of 0.89%. This is comparable to the rest of the industry: AKE outperforms 53.03% of its industry peers.
  • AKE has a Return On Equity (1.76%) which is comparable to the rest of the industry.
  • AKE's Return On Invested Capital of 2.77% is in line compared to the rest of the industry. AKE outperforms 53.03% of its industry peers.
  • Measured over the past 3 years, the Average Return On Invested Capital for AKE is in line with the industry average of 7.06%.
Industry RankSector Rank
ROA 0.89%
ROE 1.76%
ROIC 2.77%
ROA(3y)4.01%
ROA(5y)5.07%
ROE(3y)7.69%
ROE(5y)9.89%
ROIC(3y)5.57%
ROIC(5y)5.74%
AKE.PA Yearly ROA, ROE, ROICAKE.PA Yearly ROA, ROE, ROICYearly ROA, ROE, ROIC 2016 2017 2018 2019 2020 2021 2022 2023 2024 5 10 15 20

1.3 Margins

  • AKE has a Profit Margin (1.38%) which is in line with its industry peers.
  • In the last couple of years the Profit Margin of AKE has declined.
  • AKE has a Operating Margin (5.40%) which is in line with its industry peers.
  • AKE's Operating Margin has declined in the last couple of years.
  • Looking at the Gross Margin, with a value of 18.68%, AKE is doing worse than 72.73% of the companies in the same industry.
  • AKE's Gross Margin has been stable in the last couple of years.
Industry RankSector Rank
OM 5.4%
PM (TTM) 1.38%
GM 18.68%
OM growth 3Y-14.88%
OM growth 5Y-6.39%
PM growth 3Y-36.12%
PM growth 5Y-8.82%
GM growth 3Y-3.36%
GM growth 5Y-1.36%
AKE.PA Yearly Profit, Operating, Gross MarginsAKE.PA Yearly Profit, Operating, Gross MarginsYearly Profit, Operating, Gross Margins 2016 2017 2018 2019 2020 2021 2022 2023 2024 5 10 15 20

5

2. Health

2.1 Basic Checks

  • The Return on Invested Capital (ROIC) is just above the Cost of Capital (WACC), so AKE is still creating some value.
  • AKE has more shares outstanding than it did 1 year ago.
  • Compared to 5 years ago, AKE has less shares outstanding
  • Compared to 1 year ago, AKE has a worse debt to assets ratio.
AKE.PA Yearly Shares OutstandingAKE.PA Yearly Shares OutstandingYearly Shares Outstanding 2016 2017 2018 2019 2020 2021 2022 2023 2024 20M 40M 60M
AKE.PA Yearly Total Debt VS Total AssetsAKE.PA Yearly Total Debt VS Total AssetsYearly Total Debt VS Total Assets 2016 2017 2018 2019 2020 2021 2022 2023 2024 5B 10B 15B

2.2 Solvency

  • An Altman-Z score of 1.88 indicates that AKE is not a great score, but indicates only limited risk for bankruptcy at the moment.
  • Looking at the Altman-Z score, with a value of 1.88, AKE is doing worse than 66.67% of the companies in the same industry.
  • The Debt to FCF ratio of AKE is 17.51, which is on the high side as it means it would take AKE, 17.51 years of fcf income to pay off all of its debts.
  • AKE has a Debt to FCF ratio (17.51) which is comparable to the rest of the industry.
  • AKE has a Debt/Equity ratio of 0.57. This is a neutral value indicating AKE is somewhat dependend on debt financing.
  • AKE has a Debt to Equity ratio (0.57) which is comparable to the rest of the industry.
Industry RankSector Rank
Debt/Equity 0.57
Debt/FCF 17.51
Altman-Z 1.88
ROIC/WACC0.53
WACC5.24%
AKE.PA Yearly LT Debt VS Equity VS FCFAKE.PA Yearly LT Debt VS Equity VS FCFYearly LT Debt VS Equity VS FCF 2016 2017 2018 2019 2020 2021 2022 2023 2024 2B 4B 6B

2.3 Liquidity

  • A Current Ratio of 3.07 indicates that AKE has no problem at all paying its short term obligations.
  • With an excellent Current ratio value of 3.07, AKE belongs to the best of the industry, outperforming 84.85% of the companies in the same industry.
  • A Quick Ratio of 2.26 indicates that AKE has no problem at all paying its short term obligations.
  • With an excellent Quick ratio value of 2.26, AKE belongs to the best of the industry, outperforming 89.39% of the companies in the same industry.
Industry RankSector Rank
Current Ratio 3.07
Quick Ratio 2.26
AKE.PA Yearly Current Assets VS Current LiabilitesAKE.PA Yearly Current Assets VS Current LiabilitesYearly Current Assets VS Current Liabilites 2016 2017 2018 2019 2020 2021 2022 2023 2024 1B 2B 3B 4B 5B

2

3. Growth

3.1 Past

  • The earnings per share for AKE have decreased strongly by -38.40% in the last year.
  • The Earnings Per Share has been growing slightly by 0.10% on average over the past years.
  • The Revenue has decreased by -2.71% in the past year.
  • AKE shows a small growth in Revenue. Measured over the last years, the Revenue has been growing by 1.78% yearly.
EPS 1Y (TTM)-38.4%
EPS 3Y-11.49%
EPS 5Y0.1%
EPS Q2Q%-54.67%
Revenue 1Y (TTM)-2.71%
Revenue growth 3Y0.09%
Revenue growth 5Y1.78%
Sales Q2Q%-8.65%

3.2 Future

  • The Earnings Per Share is expected to decrease by -1.61% on average over the next years.
  • The Revenue is expected to grow by 0.81% on average over the next years.
EPS Next Y-43.5%
EPS Next 2Y-21.77%
EPS Next 3Y-9.88%
EPS Next 5Y-1.61%
Revenue Next Year-5.26%
Revenue Next 2Y-2.07%
Revenue Next 3Y-0.23%
Revenue Next 5Y0.81%

3.3 Evolution

  • When comparing the EPS growth rate of the last years to the growth rate of the upcoming years, we see that the growth is decreasing.
  • The Revenue growth rate is decreasing: in the next years the growth will be less than in the last years.
AKE.PA Yearly Revenue VS EstimatesAKE.PA Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 2026 2027 2028 2029 2030 2031 2032 2B 4B 6B 8B 10B
AKE.PA Yearly EPS VS EstimatesAKE.PA Yearly EPS VS EstimatesYearly EPS VS Estimates 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 2026 2027 2028 2029 2030 5 10 15

5

4. Valuation

4.1 Price/Earnings Ratio

  • AKE is valuated correctly with a Price/Earnings ratio of 12.14.
  • Based on the Price/Earnings ratio, AKE is valued cheaper than 90.91% of the companies in the same industry.
  • AKE is valuated cheaply when we compare the Price/Earnings ratio to 27.19, which is the current average of the S&P500 Index.
  • A Price/Forward Earnings ratio of 12.44 indicates a correct valuation of AKE.
  • 89.39% of the companies in the same industry are more expensive than AKE, based on the Price/Forward Earnings ratio.
  • When comparing the Price/Forward Earnings ratio of AKE to the average of the S&P500 Index (28.06), we can say AKE is valued rather cheaply.
Industry RankSector Rank
PE 12.14
Fwd PE 12.44
AKE.PA Price Earnings VS Forward Price EarningsAKE.PA Price Earnings VS Forward Price Earnings ChartPrice Earnings - Forward Price Earnings PE FPE 5 10 15 20 25

4.2 Price Multiples

  • Compared to the rest of the industry, the Enterprise Value to EBITDA ratio of AKE indicates a somewhat cheap valuation: AKE is cheaper than 78.79% of the companies listed in the same industry.
  • AKE's Price/Free Cash Flow ratio is a bit cheaper when compared to the industry. AKE is cheaper than 77.27% of the companies in the same industry.
Industry RankSector Rank
P/FCF 19.56
EV/EBITDA 6.76
AKE.PA Per share dataAKE.PA EPS, Sales, OCF, FCF, BookValue per sharePer Share Data Per Share 20 40 60 80 100

4.3 Compensation for Growth

  • AKE's earnings are expected to decrease with -9.88% in the coming years. This may justify a cheaper valuation.
PEG (NY)N/A
PEG (5Y)124.18
EPS Next 2Y-21.77%
EPS Next 3Y-9.88%

6

5. Dividend

5.1 Amount

  • AKE has a Yearly Dividend Yield of 5.51%, which is a nice return.
  • AKE's Dividend Yield is rather good when compared to the industry average which is at 2.13. AKE pays more dividend than 90.91% of the companies in the same industry.
  • Compared to an average S&P500 Dividend Yield of 1.82, AKE pays a better dividend.
Industry RankSector Rank
Dividend Yield 5.51%

5.2 History

  • On average, the dividend of AKE grows each year by 6.86%, which is quite nice.
Dividend Growth(5Y)6.86%
Div Incr Years4
Div Non Decr Years4
AKE.PA Yearly Dividends per shareAKE.PA Yearly Dividends per shareYearly Dividends per share 2019 2020 2021 2022 2023 2024 2025 1 2 3

5.3 Sustainability

  • AKE pays out 214.17% of its income as dividend. This is not a sustainable payout ratio.
  • The Dividend Rate of AKE has been growing, while earnings will be declining. This means the dividend growth is most likely not sustainable.
DP214.17%
EPS Next 2Y-21.77%
EPS Next 3Y-9.88%
AKE.PA Yearly Income VS Free CF VS DividendAKE.PA Yearly Income VS Free CF VS DividendYearly Income VS Free CF VS Dividend 2016 2017 2018 2019 2020 2021 2022 2023 2024 200M 400M 600M 800M 1B
AKE.PA Dividend Payout.AKE.PA Dividend Payout, showing the Payout Ratio.AKE.PA Dividend Payout.PayoutRetained Earnings

ARKEMA

EPA:AKE (2/16/2026, 7:00:00 PM)

62.5

-1.3 (-2.04%)

Chartmill FA Rating
GICS SectorMaterials
GICS IndustryGroupMaterials
GICS IndustryChemicals
Earnings (Last)11-07
Earnings (Next)02-26
Inst Owners59.92%
Inst Owner ChangeN/A
Ins Owners0.58%
Ins Owner ChangeN/A
Market Cap4.75B
Revenue(TTM)9.24B
Net Income(TTM)127.00M
Analysts72.73
Price Target62.02 (-0.77%)
Short Float %N/A
Short RatioN/A
Dividend
Industry RankSector Rank
Dividend Yield 5.51%
Yearly Dividend3.47
Dividend Growth(5Y)6.86%
DP214.17%
Div Incr Years4
Div Non Decr Years4
Ex-DateN/A
Surprises & Revisions
EPS beat(2)0
Avg EPS beat(2)-8.47%
Min EPS beat(2)-10.34%
Max EPS beat(2)-6.61%
EPS beat(4)0
Avg EPS beat(4)-11.01%
Min EPS beat(4)-18.44%
Max EPS beat(4)-6.61%
EPS beat(8)2
Avg EPS beat(8)-6.6%
EPS beat(12)6
Avg EPS beat(12)-0.72%
EPS beat(16)10
Avg EPS beat(16)8.4%
Revenue beat(2)0
Avg Revenue beat(2)-0.82%
Min Revenue beat(2)-1.17%
Max Revenue beat(2)-0.46%
Revenue beat(4)0
Avg Revenue beat(4)-0.78%
Min Revenue beat(4)-1.17%
Max Revenue beat(4)-0.46%
Revenue beat(8)2
Avg Revenue beat(8)-0.58%
Revenue beat(12)3
Avg Revenue beat(12)-1.09%
Revenue beat(16)7
Avg Revenue beat(16)0.41%
PT rev (1m)-3.01%
PT rev (3m)-12.99%
EPS NQ rev (1m)-0.28%
EPS NQ rev (3m)-33.96%
EPS NY rev (1m)0%
EPS NY rev (3m)-11.85%
Revenue NQ rev (1m)0%
Revenue NQ rev (3m)-0.19%
Revenue NY rev (1m)0%
Revenue NY rev (3m)-0.44%
Valuation
Industry RankSector Rank
PE 12.14
Fwd PE 12.44
P/S 0.51
P/FCF 19.56
P/OCF 4.85
P/B 0.66
P/tB 2.17
EV/EBITDA 6.76
EPS(TTM)5.15
EY8.24%
EPS(NY)5.02
Fwd EY8.04%
FCF(TTM)3.19
FCFY5.11%
OCF(TTM)12.88
OCFY20.62%
SpS121.43
BVpS94.94
TBVpS28.82
PEG (NY)N/A
PEG (5Y)124.18
Graham Number104.89
Profitability
Industry RankSector Rank
ROA 0.89%
ROE 1.76%
ROCE 3.93%
ROIC 2.77%
ROICexc 2.78%
ROICexgc 4.6%
OM 5.4%
PM (TTM) 1.38%
GM 18.68%
FCFM 2.63%
ROA(3y)4.01%
ROA(5y)5.07%
ROE(3y)7.69%
ROE(5y)9.89%
ROIC(3y)5.57%
ROIC(5y)5.74%
ROICexc(3y)6.56%
ROICexc(5y)6.98%
ROICexgc(3y)13.06%
ROICexgc(5y)13.27%
ROCE(3y)8.13%
ROCE(5y)8.28%
ROICexgc growth 3Y-19.33%
ROICexgc growth 5Y-9.22%
ROICexc growth 3Y-22.98%
ROICexc growth 5Y-11.22%
OM growth 3Y-14.88%
OM growth 5Y-6.39%
PM growth 3Y-36.12%
PM growth 5Y-8.82%
GM growth 3Y-3.36%
GM growth 5Y-1.36%
F-Score4
Asset Turnover0.65
Health
Industry RankSector Rank
Debt/Equity 0.57
Debt/FCF 17.51
Debt/EBITDA 3.1
Cap/Depr 89.12%
Cap/Sales 7.98%
Interest Coverage 20.79
Cash Conversion 73.91%
Profit Quality 191.34%
Current Ratio 3.07
Quick Ratio 2.26
Altman-Z 1.88
F-Score4
WACC5.24%
ROIC/WACC0.53
Cap/Depr(3y)97.52%
Cap/Depr(5y)93.37%
Cap/Sales(3y)7.14%
Cap/Sales(5y)7.42%
Profit Quality(3y)111.66%
Profit Quality(5y)102.9%
High Growth Momentum
Growth
EPS 1Y (TTM)-38.4%
EPS 3Y-11.49%
EPS 5Y0.1%
EPS Q2Q%-54.67%
EPS Next Y-43.5%
EPS Next 2Y-21.77%
EPS Next 3Y-9.88%
EPS Next 5Y-1.61%
Revenue 1Y (TTM)-2.71%
Revenue growth 3Y0.09%
Revenue growth 5Y1.78%
Sales Q2Q%-8.65%
Revenue Next Year-5.26%
Revenue Next 2Y-2.07%
Revenue Next 3Y-0.23%
Revenue Next 5Y0.81%
EBIT growth 1Y-33.91%
EBIT growth 3Y-14.81%
EBIT growth 5Y-4.73%
EBIT Next Year42.37%
EBIT Next 3Y16.8%
EBIT Next 5Y12.01%
FCF growth 1Y-53.98%
FCF growth 3Y33.3%
FCF growth 5Y-10.84%
OCF growth 1Y-22.65%
OCF growth 3Y7%
OCF growth 5Y-2.92%

ARKEMA / AKE.PA FAQ

What is the fundamental rating for AKE stock?

ChartMill assigns a fundamental rating of 4 / 10 to AKE.PA.


Can you provide the valuation status for ARKEMA?

ChartMill assigns a valuation rating of 5 / 10 to ARKEMA (AKE.PA). This can be considered as Fairly Valued.


How profitable is ARKEMA (AKE.PA) stock?

ARKEMA (AKE.PA) has a profitability rating of 4 / 10.


Can you provide the financial health for AKE stock?

The financial health rating of ARKEMA (AKE.PA) is 5 / 10.


Is the dividend of ARKEMA sustainable?

The dividend rating of ARKEMA (AKE.PA) is 6 / 10 and the dividend payout ratio is 214.17%.